MiR-30a inhibits autophagy in chronic myeloid leukemia and hepatocellular carcinoma (HCC) cells by selectively blocking BECN1 and ATG5, which are needed for autophagy nucleation and elongation stages respectively (Yu et al., 2012; Fu et al., 2018b). This evidence concerns the gene BECN1 and hepatocellular carcinoma.